One analysis of primary breast cancer samples revealed that ERBB2, FGFR1, MYC, CCND1, and PIK3CA were commonly amplified, and other well-known oncogenes such as CCND2, EGFR, FGFR2, and NOTCH3 were amplified at lower frequencies [88]. This evidence concerns the gene ERBB2 and breast carcinoma.